Cluster Headache Market Research, 2031

1
Cluster Headache Market 

• Cluster Headache Market to Reach USD 522.98
  Million, Globally, by 2031 at 3.9 CAGR, Claims
  Allied Market Research

2
Development of novel therapeutics for treatment
of cluster headache, awareness activities related
to headache disorders and increase in RD
activities for development of novel drugs are the
factors driving the growth of the global cluster
headache market. On the other hand, side effects
of the medications impede the growth to some
extent. However, rise in investment by the major
key players is expected to create lucrative
opportunities in the industry. Sample of the
Report-  https//www.alliedmarketresearch.com/requ
est-sample/14812 
Drivers, Restraints, and Opportunities
3
(No Transcript)
4
Leading Market Players

• Arrotex Australia Group
• AstraZeneca
• Dr. Reddy's Laboratories Ltd.
• Eli Lilly and Company
• Fresenius SE Co. KGaA
• GlaxoSmithKline plc
• Novartis AG
• Pfizer Inc
• Sun Pharmaceutical Industries Ltd
• Teva Pharmaceutical Industries Ltd

5
North America held the lion's share
North America held the major share in 2021,
garnering more thantwo fifth of the global
cluster headache market revenue owing to rise in
prevalence of cluster headache cases and increase
in number of key players offering novel
therapeutics. However, Asia-Pacific would
showcase the fastest CAGR of 4.8 from 2022 to
2031 owing to increase in number of headache
disorders, rise in awareness campaign, and surge
in investments for development of effective drugs
for treating cluster headache.
6
Contact

• David Correa
• 5933 NE Win Sivers Drive205, Portland,
  OR 97220United StatesToll Free
  1-800-792-5285 UK 44-845-528-1300Hong Kong
  852-301-84916India (Pune) 91-20-66346060Fax
  1-855-550-5975help_at_alliedmarketresearch.comWeb
   https//www.alliedmarketresearch.com  Follow Us
  on LinkedIn Twitter